0001209191-21-063671.txt : 20211109
0001209191-21-063671.hdr.sgml : 20211109
20211109172533
ACCESSION NUMBER: 0001209191-21-063671
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211105
FILED AS OF DATE: 20211109
DATE AS OF CHANGE: 20211109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Simeone Jill
CENTRAL INDEX KEY: 0001581731
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36911
FILM NUMBER: 211393383
MAIL ADDRESS:
STREET 1: C/O ETSY
STREET 2: 117 ADAMS STREET
CITY: BROOKLYN
STATE: NY
ZIP: 11201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ETSY INC
CENTRAL INDEX KEY: 0001370637
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 117 ADAMS STREET
CITY: BROOKLYN
STATE: NY
ZIP: 11201
BUSINESS PHONE: (718) 880-3660
MAIL ADDRESS:
STREET 1: 117 ADAMS STREET
CITY: BROOKLYN
STATE: NY
ZIP: 11201
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-11-05
0
0001370637
ETSY INC
ETSY
0001581731
Simeone Jill
C/O ETSY, INC.
117 ADAMS STREET
BROOKLYN
NY
11201
0
1
0
0
Chief Legal Officer
Common Stock
2021-11-05
4
M
0
12730
12.46
A
30322
D
Common Stock
2021-11-05
4
M
0
22709
14.72
A
53031
D
Common Stock
2021-11-05
4
M
0
15000
28.38
A
68031
D
Common Stock
2021-11-05
4
S
0
6672
257.58
D
61359
D
Common Stock
2021-11-05
4
S
0
23103
258.38
D
38256
D
Common Stock
2021-11-05
4
S
0
7400
259.79
D
30856
D
Common Stock
2021-11-05
4
S
0
1690
260.53
D
29166
D
Common Stock
2021-11-05
4
S
0
16700
261.99
D
12466
D
Common Stock
2021-11-05
4
S
0
1476
263.38
D
10990
D
Common Stock
2021-11-05
4
S
0
124
264.10
D
10866
D
Common Stock
2021-11-09
4
M
0
2250
28.38
A
13116
D
Common Stock
2021-11-09
4
S
0
2250
261.00
D
10866
D
Stock Option (Right to Buy)
12.46
2021-11-05
4
M
0
12730
0.00
D
2027-01-31
Common Stock
12730
0
D
Stock Option (Right to Buy)
14.72
2021-11-05
4
M
0
22709
0.00
D
2027-07-02
Common Stock
22709
0
D
Stock Option (Right to Buy)
28.38
2021-11-05
4
M
0
15000
0.00
D
2028-03-14
Common Stock
15000
24303
D
Stock Option (Right to Buy)
28.38
2021-11-09
4
M
0
2250
0.00
D
2028-03-14
Common Stock
2250
22053
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.93 to $257.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.93 to $258.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.19 to $260.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.22 to $260.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.61 to $262.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $262.93 to $263,85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $264.045 to $264.125, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.97 to $261.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares underlying the option exercised in this transaction were fully vested and exercisable. 25% of the stock options became exercisable on February 1, 2018, with the remainder of the originally granted options exercisable in 36 equal monthly installments beginning on March 1, 2018, provided the Reporting Person remains continuously employed on each vesting date.
The shares underlying the option exercised in this transaction were fully vested and exercisable. 25% of the stock options became exercisable on July 3, 2018, with the remainder of the originally granted options exercisable in 36 equal monthly installments beginning on August 3, 2018, provided the Reporting Person remains continuously employed on each vesting date.
The shares underlying the option exercised in this transaction were fully vested and exercisable. The stock options become exercisable in 8 equal semi-annual installments, beginning on October 1, 2018, provided the Reporting Person remains continuously employed on each vesting date.
/s/ Brittany Keen, as Attorney-in-Fact for Jill Simeone
2021-11-09